Brief: Creso Pharma Posts Qtrly Total Unaudited Revenue Of A$2.3 Million
April 28 (Reuters) - Creso Pharma Ltd CPH.AX :
* QTRLY TOTAL UNAUDITED REVENUE OF A$2.3 MILLION
Source text for Eikon: ID:nASX1ZSc0J
Further company coverage: CPH.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale